Partial response to Cyclosporine in a patient with Schnitzler's syndrome

Allergologia et Immunopathologia

Volumn 35, Issue 2, 2007, Pages 71-73

  Carbone, Javier ^a   Paravisini, A ^a   Sarmiento, E ^a   Rodriguez Molina J ^a   Fernandez Cruz E ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Chronic urticaria; Cyclosporine; Paraprotein; Schnitzler's syndrome

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN M; METHYLPREDNISOLONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC URTICARIA; CLINICAL FEATURE; DOSE RESPONSE; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LOW DRUG DOSE; PHYSICAL EXAMINATION; SCHNITZLER SYNDROME;

EID: 34249823073     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13101341     Document Type: Article

References (15)

1. nd presentation. Bull Soc Fr Dermatol Syphil. 1974;81:363.
2. Harati A, Brockmeyer NH, Altmeyer P, Kreuter A. Skin disorders in association with monoclonal gammopathies. Eur J Med Res. 2005;10:93-104.
3. Germain P, Fach J, Bui N, Traissac T, Delbrel X, Le Bras M, et al. Schnitzler syndrome: a rare cause of systemic urticaria. Rev Med Interne. 2000;21:285-9.
4. Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E. The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore). 2001;80:37-44.
5. Winckelmann G, Nagel HG, Maier R, Reuther G. The Schnitzler syndrome as a cause of recurrent fever of unknown origin. Dtsch Med Wochenschr. 1996;121:860-4.
6. Lim W, Shumak KH, Reis M, Pérez-Ordóñez B, Sauder D, Fam A, et al. Malignant evolution of Schnitzler's syndrome-chronic urticaria and IgM monoclonal gammopathy: report of a new case and review of the literature. Leuk Lymphoma. 2002;43:181-6.
7. Barriere H, Schnitzler L, Moulin G, Grolleau Y. Chronic urticarial lesions and macroglobulinemia. Apropos of 5 cases. Sem Hop. 1976;52:221-7.
8. De Castro FR, Masouye I, Winkelmann RK, Saurat JH. Urticarial pathology in Schnitzler's (hyper-IgM) syndrome. Dermatology. 1996;193:94-9.
9. Lipsker D, Spehner D, Drillien R, Schmitt P, Cribier B, Heid E, et al. Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol. 2000;142:954-9.
10. Schartz NE, Buder S, Sperl H, Audring H, Paus R, Tebbe B, et al. Report of a case of Schnitzler's syndrome treated successfully with interferon alpha 2b.Dermatology. 2002;205:54-6.
11. Peterlana D, Puccetti A, Tinazzi E, Simeoni S, Lunardi C. Schnitzler's syndrome treated successfully with intravenous pulse cyclophosphamide. Scand J Rheumatol. 2005;34: 328-30.
12. Toubi E, Blant A, Kessel A, Golan TD. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy. 1997;52:312-316.
13. Di Gioacchino M, Si Stefano F, Cavallucci E, Verna N, Ramonso S, Paolini F, et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc. 2003;24:285-90.
14. Vena GA, Cassano N, Colombo D, Peruzzi E, Pigatto P; Neo-l-30 Study Group. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2006;55:705-9.
15. Pascual-López M, Hernández-Núñez A, Sánchez-Pérez J, Fernández-Herrera J, García- Díez A. Schnitzler's syndrome with monoclonal IgG kappa gammopathy: good response to cyclosporin. J Eur Acad Dermatol Venereol. 2002;16:267-70.